Freeze and fight: new combo tackles early lung cancer without surgery
Disease control
Not yet recruiting
This phase II trial tests whether combining cryoablation (freezing the tumor) with the immunotherapy drug serplulimab can treat early-stage non-small cell lung cancer in people who cannot have surgery or radiation. Twenty-five adults with stage Ia NSCLC will receive one cryoablat…
Phase: PHASE2 • Sponsor: Xi Junjie • Aim: Disease control
Last updated Jun 26, 2026 16:59 UTC